skip to navigation skip to content

Business Weekly: Cambridge startup hopes to raise £7.5m diabetes cash


An interview with Dr Arjun Jain, founder and CEO of the ET-traps startup that focuses on diabetes. “Currently available therapies are mainly limited to glucose control medications and medications to treat the disease complications, so they do not prevent progression of disease that is linked to irreversible damage to the vital organs,” he said. The startup was previously on the Accelerate Cambridge programme run by the Entrepreneurship Centre at the School.

Read the full article []